Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2001;60:777-780; doi:10.1136/ard.60.8.777
Copyright © 2001 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 2001;60:777-780 ( August )

Extended report

Specific glycosylation of alpha 1-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV D C W Polanda, J P H Drenthb, E Rabinovitzc, A Livnehc, J Bijzetd, B van het Hofa, W van Dijka

a Department of Medical Chemistry, Institute for Inflammation and Inflammatory Diseases, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands, b Department of Medicine, Division of Gastroenterology, University Medical Centre St Radboud, Nijmegen, The Netherlands, c Heller Institute of Medical Research, Sheba Medical Centre, Tel Hashomer and Sackler School of Medicine, Tel Aviv, Israel, d Division of Rheumatology, Department of Medicine, University Hospital, Groningen, The Netherlands

Correspondence to: Dr W Van Dijk, Department of Medical Chemistry, Institute for Immunology and Inflammatory Diseases, Faculty of Medicine, Vrije Universiteit, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands w.van_dijk.medchem{at}med.vu.nl

Accepted for publication 23 January 2001

BACKGROUND---Familial Mediterranean fever (FMF) is a periodic febrile disorder, characterised by fever and serositis. The acute phase response during attacks of FMF results from the release of cytokines, which in turn induce increased expression and changed glycosylation of acute phase proteins. A recent study indicated that attacks in FMF are accompanied by a rise of plasma concentrations of serum amyloid A (SAA) and C reactive protein (CRP), which remain significantly raised during remission relative to healthy controls. Another study suggested that obligatory heterozygotes also display an inflammatory acute phase response.
OBJECTIVE---To determine the state of inflammation in homozygotic and heterozygotic MEFV genotypes.
METHODS---CRP and SAA were studied by enzyme linked immunosorbent assay (ELISA). The glycosylation of the acute phase protein, alpha 1-acid glycoprotein (AGP), was visualised with crossed affinoimmunoelectrophoresis with concanavalin A as diantennary glycan-specific component and Aleuria aurantia lectin as fucose-specific affinity component.
RESULTS---FMF attacks were associated with an increase (p<0.05) in the serum inflammation parameters CRP, SAA, and AGP. The glycosylation of AGP showed an increase (p<0.05) in fucosylated AGP glycoforms, whereas the branching of the glycans remained unaffected. The glycosylation of AGP in the MEFV carrier group, compared with that in a healthy control group, was characterised by a significant increase (p<0.05) in branching of the glycans, whereas the fucosylation remained unaffected.
CONCLUSION---The findings suggest an FMF-specific release of cytokines, resulting in a different glycosylation of AGP between a homozygotic and heterozygotic MEFV genotype.


© 2001 by Annals of the Rheumatic Diseases

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs